TCL Archive In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER March 20, 1992
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive Cooperative Group Reorganization To Be Offered By DeVita At Clinical Trials Review Next March October 20, 1978
TCL Archive Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins January 9, 1987
